RESUMEN
OBJECTIVE: To assess if the amount of postoperative postvoid residual of urine that is within the normal range (less than 100â¯mls) could predict the outcome of TVTO (Tension -free vaginal tape obturator) procedure. STUDY DESIGN: Second Department of Obstetrics and Gynecology, Aretaieio Hospital, University of Athens, Greece. Patients that had been submitted to TVTO procedure between 2013 and 2017 were reviewed and outcome was assessed.The follow up assessment included cough stress test, the Patient Satisfaction Questionnaire (PSQ), the Urinary Distress Inventory-6 (UDI-6) and the Patient Global Impression of Improvement (PGI-I) questionnaire. RESULTS: The mean follow-up was 3.7â¯years (+1.35 years). Forty eight patients (40.3%) had only a TVTO procedure. Forty three patients (36.1%) had a TVTO procedure combined with anterior colporrhaphy. Twenty eight patients (23.6%) underwent a TVTO procedure and anterior colporrhaphy and posterior colpoperineorrhaphy. According to cough stress test 88% patients (105/119) were cured having a negative cough stress test. Using logistic regression analysis it was found that patient's age (pâ¯=â¯0.78), postoperative postvoid residual of urine (â¯=â¯0.24) or day of catheter removal (pâ¯=â¯0.22) had no statistically significant correlation with the medium term outcome of TVTO procedure. Also, regression analysis shows that patients' Body Mass Index (BMI) has negative correlation to the postoperative outcome. CONCLUSION(S): PVRâ¯<â¯50 mls appears to be related with successful medium term outcome after TVTO procedure. Also, patients' (BMI) has negative correlation to the postoperative outcome.
Asunto(s)
Calidad de Vida , Cabestrillo Suburetral , Incontinencia Urinaria/cirugía , Urodinámica , Anciano , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Periodo Posoperatorio , Encuestas y Cuestionarios , Resultado del TratamientoRESUMEN
Disruption of vaginal microbiota equilibrium promotes infectious clinical syndromes with annoying symptoms, such as vaginal discharge, odour, irritation, pruritus, and vulvar burning. Although identifying and eradicating the pathogen involved has been the standard of care, regional microbiota restoration with probiotics has been gaining ground in recent years. This study aimed to assess the effectiveness of topical Bacillus coagulans treatment for patients exhibiting vaginal discomfort symptoms. A clinical trial was conducted on the use of a topical B. coagulans regimen among reproductive-age women (n=70) with vaginal discomfort symptoms. We assessed their symptoms using a questionnaire, measured vaginal pH, and performed vaginal swabs for microscopy and cultivation. Over the next 4 days, patients received B. coagulans vaginal douches and suppositories with appropriate antibiotic treatment being added on the fourth day based on vaginal swab results. Patients returned 16 days later to fill out in the questionnaire again. The Wilcoxon signed-ranked test was then used to assess differences in symptomatology and pH between appointments. A reduction in vaginal pH was reported between the first and second visit (P<0.001). The probiotic regimen exerted a beneficial effect in all vaginal manifestations: vulvovaginal itching, burning sensation, vaginal irritation, and vaginal discharge (P<0.001 for all symptoms). Additionally, three out of the four symptoms were alleviated to a greater extent during the first four days of exclusive probiotic use than during the second phase (P=0.007, P=0.004, and P=0.033). Our sample provided significant results regarding the benefits of B. coagulans for vaginal discomfort. We postulate that the greatest symptom improvement was achieved within the first 4 days of exclusive probiotic use, before the addition of antibiotics. This study agrees with the increasing literature on the contribution of probiotics toward vaginitis treatment.
Asunto(s)
Probióticos/administración & dosificación , Probióticos/farmacología , Vagina/efectos de los fármacos , Vulvovaginitis/terapia , Administración Intravaginal , Adolescente , Adulto , Antiinfecciosos/administración & dosificación , Antiinfecciosos/farmacología , Bacillus coagulans , Femenino , Humanos , Concentración de Iones de Hidrógeno , Persona de Mediana Edad , Resultado del Tratamiento , Vagina/química , Vagina/microbiología , Vagina/patología , Vulvovaginitis/microbiología , Vulvovaginitis/patología , Adulto JovenRESUMEN
Surrogacy is an assisted reproduction-based approach in which the intended parents assign the gestation and birth to another woman called the surrogate mother. The drivers of surrogacy refer largely to infertility, medical conditions, same-sex couples' parenting, and cases of diversity regarding sexual identity and orientation. Surrogacy consists of a valid option for a variety of conditions or circumstances ranging from medical to social reasons. However, surrogacy may be associated with risks during the preimplantation, prenatal, and neonatal period. It became obvious during the exhaustive literature research that data on surrogacy and its association with factors specific to the IVF practice and the options available were not fully represented. Could it be that surrogacy management adds another level of complexity to the process from the ovarian stimulation, the subsequent IVF cycle, and the techniques employed within the IVF and the Genetic Laboratory to the fetal, perinatal, and neonatal period? This work emphasizes the risks associated with surrogacy with respect to the preimplantation embryo, the fetus, and the infant. Moreover, it further calls for larger studies reporting on surrogacy and comparing the surrogate management to that of the routine IVF patient in order to avoid suboptimal management of a surrogate cycle. This is of particular importance in light of the fact that the surrogate cycle may include not only the surrogate but also the egg donor, sperm donor, and the commissioning couple or single person.
Asunto(s)
Infertilidad , Atención Prenatal , Madres Sustitutas , Femenino , Humanos , Lactante , Parto , Embarazo , RiesgoRESUMEN
OBJECTIVES: To clarify potential differences between denosumab (DNS) and bisphosphonates (BIS) in terms of bone density and bone metabolism, in a sample of postmenopausal women. METHODS: A total of 113 postmenopausal women aged 53-66 years were treated with either DNS or BIS for 12 months. Bone densitometry and laboratory tests were compared between baseline and follow-up. RESULTS: Femoral neck BMD increased in both treatment-arms (FN-BMD, DNS: 0.69±0.07 g/cm2 to 0.75±0.09 g/cm2; BIS: 0.69±0.06 g/cm2 to 0.71±0.07 g/cm2; p≤0.001 in both cases). Lumbar spine BMD (LS-BMD) increased significantly only in the DNS-group (0.83±0.14 g/cm2 to 0.89±0.14 g/cm2, p=0.0001). Only women under treatment with DNS had a significant increase in serum parathyroid hormone (PTH: 44.87±17.54 pg/mL to 53.27±15.77 pg/mL, p=0.04), independently of baseline vitamin D levels. DNS-administration resulted in higher increase from baseline in FN-BMD compared to BIS (DNS vs BIS: 8.7%±8.5 vs 3.8%±7.3, p=0.004). Finally, baseline 25OH vitamin D levels did not determine the extent of PTH-increase following administration of DNS- or BIS-treatment. CONCLUSIONS: Both treatments increased BMD, however, the effect of DNS on FN-BMD was superior compared to that of BIS. DNS-treatment increased serum PTH. Baseline 25OH vitamin D levels did not predict the extent of PTH increase at follow-up.
Asunto(s)
Densidad Ósea/efectos de los fármacos , Calcio/metabolismo , Denosumab/farmacología , Difosfonatos/farmacología , Posmenopausia/efectos de los fármacos , Posmenopausia/metabolismo , Anciano , Densidad Ósea/fisiología , Conservadores de la Densidad Ósea/farmacología , Conservadores de la Densidad Ósea/uso terapéutico , Denosumab/uso terapéutico , Difosfonatos/uso terapéutico , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Osteoporosis Posmenopáusica/metabolismo , Osteoporosis Posmenopáusica/prevención & control , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
OBJECTIVE: To determine whether in vitro fertilization (IVF), frozen replacement cycles offer better outcomes than fresh cycles in order to support, or not, a possible shift towards total replacement of fresh IVF/intracytoplasmic sperm injection (ICSI) cycles from frozen elective transfers (FETs). STUDY DESIGN: Systematic review; opinion paper. RESULTS: Initial results seem to support a shift in current practice towards frozen cycles. CONCLUSION: Initial results may support replacement all fresh IVF/ICSI cycles with FETs, as this could be a safer and equally effective strategy. However, robust evidence from randomized controlled trials is needed if this will be generally applied.
Asunto(s)
Criopreservación , Transferencia de Embrión , Embrión de Mamíferos , Femenino , Fertilización In Vitro , Congelación , Humanos , Embarazo , Índice de Embarazo , Inyecciones de Esperma IntracitoplasmáticasRESUMEN
This is a prospective study of the epidemiological, clinical, and virological characteristics of cases of genital warts in a Greek University Hospital. The women completed a questionnaire regarding their medical and sexual history and underwent cervical cytology, HPV DNA typing, mRNA testing, colposcopy, Chlamydia testing, and proctoscopy. Univariate and multivariate analyses were performed. The most commonly detected types were type 6 (36.1%) and 16 (24.3%). E6/E7 mRNA testing was positive in 21.5%. Concurrent cervical intraepithelial neoplasia grade 2 or worse was found in 11.1% and intra-anal warts in 10.4%. For chlamydial infection the number of sexual partners was a significant predictor. Women with warts infected with types 6 and 11 constituted only 37.5% of the total. This could have a negative effect on the efficacy of vaccination in reducing the incidence of the disease. Based on the present findings the authors recommend cytology and colposcopy for all women with genital warts.
Asunto(s)
Condiloma Acuminado/epidemiología , Condiloma Acuminado/virología , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Adulto , Infecciones por Chlamydia/epidemiología , Colposcopía , Citodiagnóstico , Femenino , Grecia/epidemiología , Humanos , Incidencia , Estudios Prospectivos , Factores de Riesgo , Conducta Sexual , Parejas Sexuales , Frotis Vaginal , Adulto JovenRESUMEN
Excessive uterine bleeding during the early years after menarche can be worrisome to the girl and her parents. The most prevalent diagnosis set is Dysfunctional uterine bleeding (DUB), after thorough examination and exclusion of other causes of abnormal uterine bleeding. The aim of this article was to review our knowledge and share our experience as tertiary reference center of pediatric-adolescent gynecology in Greece. We conducted a review of current literature using Pubmed and MedLine as our primary databases, as well as providing commentary considering work up, treatment and follow-up of our DUB patients. Insufficient progesterone production and subsequent abnormal shedding of the endometrium appears to orchestrate the pathophysiology of DUB in adolescence. Hypothalamic-pituitary-ovarian (HPO) axis immaturity right after menarche, is usually the most plausible cause. Nevertheless, it is necessary to exclude other, possibly even life-threatening causes. Complete work up including physical examination, laboratory and imaging studies (complete blood count, b-HCG, hormonal levels and ultrasonography) is needed, and appropriate treatment with combined oral contraceptives is administered accordingly. Although menstrual disorders are very common in early adolescence, a severe episode of DUB should always be thoroughly attended by any physician. Follow-up should be offered in all young patients due to high incidence of recurrence or subsequent development of endocrine disorders such as Polycystic Ovary Syndrome (PCOS).
Asunto(s)
Anticonceptivos Orales Combinados/administración & dosificación , Metrorragia/etiología , Síndrome del Ovario Poliquístico/diagnóstico , Adolescente , Endometrio/metabolismo , Femenino , Grecia , Humanos , Sistema Hipotálamo-Hipofisario/metabolismo , Metrorragia/fisiopatología , Síndrome del Ovario Poliquístico/complicaciones , Progesterona/metabolismoRESUMEN
PURPOSE OF THE STUDY: Aberrant activation of the Akt/mTOR/pS6 signaling pathway has been identified in various types of cancer and is under investigation in cervical cancer. The purpose of this study was to assess the expression of the phosphorylated/activated forms of Akt (upstream molecule), 4E-BP1 and pS6 (downstream molecules) in biopsy samples of cervical low grade squamous intraepithelial lesions (LSIL), high grade squamous intraepithelial lesions (HSIL), and squamous cell carcinoma (Ca) compared to normal cervical epithelium. MATERIAL AND METHODS: The study included 38 cases diagnosed as LSIL, 31 cases as HSIL, 29 cases as Ca, and eight control cases from normal cervix. Immunohistochemistry was used to assess the expression of pAkt, p4E-BP1 and pS6. RESULTS: Statistical analysis revealed significant differences between HSIL and Ca groups compared to controls regarding intensity, positivity, and total scores for all three molecules (p < 0.001). A trend for higher expression with increasing grade of dysplasia was demonstrated. CONCLUSION: These results strongly support the view that the mTOR signaling pathway is involved in cervical carcinogenesis.
Asunto(s)
Carcinoma de Células Escamosas/química , Lesiones Precancerosas/química , Transducción de Señal , Serina-Treonina Quinasas TOR/metabolismo , Displasia del Cuello del Útero/química , Neoplasias del Cuello Uterino/química , Proteínas Adaptadoras Transductoras de Señales/análisis , Carcinoma de Células Escamosas/metabolismo , Proteínas de Ciclo Celular , Femenino , Humanos , Fosfoproteínas/análisis , Fosforilación , Lesiones Precancerosas/metabolismo , Proteínas Proto-Oncogénicas c-akt/análisis , Proteínas Quinasas S6 Ribosómicas/análisis , Neoplasias del Cuello Uterino/metabolismo , Displasia del Cuello del Útero/metabolismoRESUMEN
BACKGROUND: Several important socio-behavioral public health problems that either peak or start during the second decade of life contribute to young people's mortality. The aim of this study was to explore patterns, rates, trends and regional variations of external-cause (due to environmental events/circumstances) mortality among young people aged 10-24 years in Greece, over the decade 2000-09. METHODS: Data were electronically derived from the database of the Hellenic Statistical Authority to study general and specific mortality rates by major causes of death. RESULTS: Road traffic crashes (RTCs), illicit drug use and suicide accounted for 65.8, 14.7 and 4.8%, of total external-cause mortality, respectively. Mortality rates (deaths per 100 000) did not exhibit intra-country variability, were higher in young adults than in adolescents, in males than in females and decreased by 39%, from 33.6 in 2000 to 20.4 in 2009 (P < 0.001), due to declines in mortality from RTCs (from 21.3 to 14.3; P = 0.001), substance abuse (from 5.1 to 2.1; P = 0.003) and suicides (from 2.0 to 0.9; P = 0.003). CONCLUSIONS: External causes of young people's mortality were mainly psychosocial and behavioral in origin. Despite improvement over the decade, young people in Greece still have unmet health-care needs and may further benefit from a multipronged public health approach through improved youth-friendly health services.
Asunto(s)
Accidentes de Tránsito/tendencias , Causas de Muerte/tendencias , Comportamiento de Búsqueda de Drogas/tendencias , Mortalidad/tendencias , Suicidio/tendencias , Accidentes de Tránsito/historia , Adolescente , Conducta del Adolescente , Adulto , Niño , Femenino , Predicción , Grecia , Historia del Siglo XXI , Humanos , Masculino , Factores Sexuales , Trastornos Relacionados con Sustancias/mortalidad , Suicidio/historia , Adulto JovenRESUMEN
The most frequent ovarian germ cell tumors are mature cystic teratomas (MCTs), composing 10-25% of all ovarian neoplasms. MCTs have the potential of undergoing malignant transformation, typically in postmenopausal women, with a frequency of 0.17-3%, with squamous cell carcinoma being the most common malignant tumor arising from MCT. We present the rare clinical entity of a squamous cell carcinoma arising from a mature cystic teratoma in a 56-year-old premenopausal woman as well as diagnostic and therapeutic route followed.
Asunto(s)
Carcinoma de Células Escamosas/patología , Neoplasias Primarias Múltiples/patología , Neoplasias Ováricas/patología , Teratoma/patología , Carcinoma de Células Escamosas/cirugía , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Primarias Múltiples/cirugía , Neoplasias Ováricas/cirugía , Teratoma/cirugíaRESUMEN
Anorexia nervosa is a serious eating disorder that is associated with decreased bone mineral density and greater lifetime risk for fractures. This case-controlled study, analyzed single nucleotide polymorphisms of genes encoding vitamin D receptor, estrogen receptor alpha (ESR1), collagen type I and calcitonin receptor (CTR). Relationships between genotype and body mass index, cycling status and lumbar spine bone mineral density (LBMD) were determined in 40 adolescent girls with anorexia nervosa and 10 age-matched controls. The distribution of CTR-AluI genotypes differed between groups, but this polymorphism was not associated with LBMD Z-score. Distribution of ESR1-XbaI genotypes did not differ between groups, but the AA genotype was associated with decreased LBMD Z-score (≤-1) (OR = 24.79, 95% CI, 1.01-606.08). Carriers of the A allele were more likely to have decreased LBMD Z-scores compared with carriers of the G allele (OR = 4.12, 95% CI, 1.23-13.85, p = 0.022). In conclusion, our study shows that anorexic patients with wild-type genotype ESR-XbaI receptor are in greater risk for decreased BMD in relation to those with the mutated gene. Prompt recognition of these patients is crucial because early administration of the proper therapeutic treatment may contribute to the prevention of adverse sequelae on bone metabolism.
Asunto(s)
Anorexia Nerviosa/genética , Densidad Ósea/genética , Receptor alfa de Estrógeno/genética , Osteoporosis/genética , Receptores de Calcitonina/genética , Receptores de Calcitriol/genética , Receptores de Colágeno/genética , Adolescente , Anorexia Nerviosa/complicaciones , Estudios de Casos y Controles , Niño , Femenino , Predisposición Genética a la Enfermedad , Humanos , Integrina alfa2beta1 , Región Lumbosacra , Osteoporosis/complicaciones , Proyectos Piloto , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Adulto JovenRESUMEN
OBJECTIVE: To assess the interaction of the MTHFR C677T polymorphism with changes in lipid and glucose metabolism effected by oral hormone replacement therapy (HRT) in postmenopausal women. METHODS: In this open-label, prospective, interventional study, parameters of lipid and glucose metabolism, as well as homocysteine, were assessed in 97 postmenopausal women at baseline and 1 year after the initiation of HRT. Participants were stratified into three subgroups, according to the MTHFR C677T polymorphism (wild-type: CC genotype; heterozygous: CT genotype; homozygous for the mutant variable: TT genotype). RESULTS: The TT genotype was associated with an elevation of total and low density lipoprotein (LDL) cholesterol, while CT and CC genotypes were associated with a reduction of total cholesterol and LDL cholesterol after 1 year of HRT (p = 0.032 for total cholesterol and p = 0.002 for LDL cholesterol). Women with the TT genotype had higher glucose levels in contrast to women with the CC genotype who had lower glucose levels after 1 year of HRT (p = 0.011). Additionally, CC carriers under HRT had a significant elevation of apolipoprotein A1 levels (p = 0.018), contrarily to CT and TT genotypes. CONCLUSION: While HRT was associated with favorable changes in lipid and metabolic parameters in carriers of the CC genotype, this effect was not evident in carriers of the T allele. The MTHFR C677T polymorphism may modify the effect of HRT on lipid and metabolic parameters in postmenopausal women.
Asunto(s)
Terapia de Reemplazo de Estrógeno , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Polimorfismo Genético , Posmenopausia/metabolismo , Adulto , Glucemia/análisis , Índice de Masa Corporal , Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Genotipo , Glucosa/metabolismo , Homocisteína/sangre , Humanos , Metabolismo de los Lípidos , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento , Triglicéridos/sangreRESUMEN
UNLABELLED: PURPOSE OF LNVESTIGATION: To examine the relationship between maternal plasma progesterone along with corticotropin- releasing hormone (CRH) plasma levels and the progression of labor. MATERIALS AND METHODS: Maternal serum CRH and progesterone were measured during the latent phase of labor, active labor, and 24 hours postpartum in women who went into spontaneous labor and delivered vaginally at term. Progesterone (P) levels in women delivered by an elective cesarean section at term were also measured as baseline. RESULTS: Mean maternal plasma P was 18% higher in the active phase than in the latent phase of labor (p < 0.01), and declined significantly by 24 hours postpartum (p < 0.001). Mean level of serum CRH was 24% higher in the active phase than in the latent phase of labor (p < 0.01), and subsequently declined significantly by 24 hours postpartum (p < 0.001). CONCLUSIONS: As labor progresses, P and CRH increase and subsequently decrease precipitously in the immediate postpartal period. P levels tend to drop in women who are in early labor compared with non-laboring full-term women.
Asunto(s)
Hormona Liberadora de Corticotropina/sangre , Trabajo de Parto/sangre , Progesterona/sangre , Cesárea , Femenino , Humanos , Periodo Posparto/sangre , EmbarazoRESUMEN
Mayer-Rokitansky-Küster-Hauser Syndrome (MRKHS) is characterized by complete or partial absence of the vagina, uterus and proximal fallopian tubes and diagnosis is usually made in late adolescence, when primary amenorrhea appears as the major symptom. Polycystic Ovary Syndrome (PCOS), which is the most common endocrine disorder among women of reproductive age, includes a variety of clinical manifestations (menstrual irregularities, hirsuitism, acne, alopecia, obesity and infertility), due to androgen hypersecretion, insulin resistance and chronic anovulation. Both MRKHS and PCOS have been studied concerning the psychological aspects and have been associated with emotional distress as well as self-esteem, body image, identity and femininity impairment. The purpose of this study was to assess psychological functioning in adolescents with uterovaginal agenesis and primary amenorrhea due to MRKHS and those with hyperandrogenism and oligomenorrhea due to PCOS, compared with healthy adolescents. The participants were 70 adolescent girls, of whom 24 with MRKHS, 22 with PCOS and 24 healthy eumenorrheic adolescents (control group) matched by age and school grade. Psychological assessment included self report questionnaires, standardized in Greek population sample. Particularly, the "Beck Depression Inventory" (BDI), the "State-Trait Anxiety Inventory" (STAI-Gr) and the "Youth Self Report" (YSR) were used to measure depression, anxiety and psychopathology respectively, while the "Symptom Checklist-90-R" was used to measure psychopathology for the patients >18 years old. The results showed significantly higher scores on the state - anxiety scale for the MRKHS group compared with the control group. The MRKHS patients in late adolescence (18-20 years old) presented also significantly higher scores in depression and psychopathology scales (symptoms of anxiety, aggressive behavior and phobic disorder) than PCOS patients of the same age. On the contrary, regarding PCOS patients, age was negative correlated with attention problems and PCOS patients >18 reported significantly more somatic complaints compared with age-mate MRKHS patients and controls. PCO syndrome's clinical manifestations, including menstrual disorders, hirsuitism, acne, alopecia, obesity and infertility, may cause significant emotional distress. Nevertheless, they appear in great variety and our sample is characterized by mild features of hyperandrogenism and oligomenorrhea. This may explain findings of milder psychological disturbance associated with PCOS in this sample in comparison to other studies. As far as MRKHS is concerned, diagnosis and loss of reproductive ability, especially in late adolescence, obstruct emotional stability, physical maturity and sexual identity development ending that are expected in this period of life. Undoubtedly, the management of MRKHS in adolescence constitutes a complex multidisciplinary issue and psychological support of patients is needed in order to prevent possible psychological consequences and to achieve a normal transition to adulthood. Among the limitations of this study is the small sample size, which limits the generalisability of the reported results, especially in "Youth Self Report" and in "Symptom Checklist-90-R" questionnaires, where the sample was divided according to the age. Nevertheless, the very low incidence of MRKHS (1/5000) emphasize the value of the present results, which support the need for further investigation.
Asunto(s)
Enfermedades de los Genitales Femeninos/congénito , Enfermedades de los Genitales Femeninos/psicología , Trastornos Mentales/etiología , Trastornos Mentales/psicología , Síndrome del Ovario Poliquístico/psicología , Útero/crecimiento & desarrollo , Vagina/crecimiento & desarrollo , Adolescente , Femenino , Humanos , Escalas de Valoración Psiquiátrica , Adulto JovenRESUMEN
This is a case of a 43-year-old primigravida primipara woman who presented in our Department in 36 weeks gestational age and underwent caesarean section due to preeclampsia. From her history, it was known that her pregnancy was an in vitro fertilization (IVF) result. She also received low molecular weight heparin because of thrombophilia (protein S insufficiency). We present this case of postpartum thrombocytosis and discuss the differential diagnosis of this condition through the presentation of its management.
Asunto(s)
Trastornos Puerperales/diagnóstico , Trombocitosis/diagnóstico , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Trastornos Puerperales/terapia , Trombocitosis/terapiaRESUMEN
Polycystic ovarian syndrome (PCOS) is an endocrine disorder affecting 5-10% of reproductive-age women. Hyperandrogenemia, which characterizes the syndrome, stimulates the maturation of adipocytes and favors central obesity. The linking hub between obesity and other metabolic manifestations of the syndrome seems to be chronic low-grade inflammation. We discuss the most reliable current data regarding the role of inflammatory mediators in PCOS, with particular focus on the genetic mechanisms implicated. C-reactive protein levels are 96% higher in PCOS patients than in healthy controls. Patients with the -308A polymorphism of the tumor necrosis factor-α gene have elevated androgens in comparison with carriers of the -308G. Interleukin 18 (IL-18) is elevated in lean patients, with a further rise in the presence of obesity and insulin resistance. Polymorphisms of the IL-1a, IL-1b and IL-6 genes have also been associated with PCOS. Plasminogen activator inhibitor-1 levels are positively associated with the syndrome, and carriers of the 4G allele of the 4G/5G polymorphism are at risk of developing PCOS. Other mediators discussed include adhesion molecules, osteoprotegerin, asymmetric dimethylarginine, homocysteine and advanced glycation end-products. The elucidation of the pathogenetic mechanisms implicated in PCOS and their connection with low-grade inflammation may in the future offer the opportunity for the formulation of novel therapeutic strategies and individualized therapy for these patients.
Asunto(s)
Mediadores de Inflamación/metabolismo , Síndrome del Ovario Poliquístico/inmunología , Tejido Adiposo/inmunología , Tejido Adiposo/metabolismo , Trastornos de la Coagulación Sanguínea/etiología , Moléculas de Adhesión Celular/sangre , Moléculas de Adhesión Celular/metabolismo , Endotelio Vascular/inmunología , Endotelio Vascular/metabolismo , Endotelio Vascular/fisiopatología , Femenino , Predisposición Genética a la Enfermedad , Humanos , Mediadores de Inflamación/sangre , Síndrome del Ovario Poliquístico/genética , Síndrome del Ovario Poliquístico/metabolismo , Síndrome del Ovario Poliquístico/fisiopatología , Polimorfismo Genético , Factores de Riesgo , Tromboembolia/epidemiología , Tromboembolia/etiologíaRESUMEN
AIM: The aim of this study was to underline the significance of premenarcheal gynecological examination in patients with transverse vaginal septum that could possibly be complicated with endometriosis. DESIGN: Retrospective study including the period between January 2008 and December 2010. SETTING: Second Department of Obstetrics and Gynecology. PATIENTS: We searched our databases regarding cases of hematocolpos caused by transverse vaginal septum. MAIN OUTCOME: Among the patients presented with hematocolpos we identified 4 cases caused by transverse vaginal septum. RESULTS: We present the management of these cases regarding diagnosis, differential diagnosis, and treatment. The mean age of the patients was 13.1 years. All patients presented in our department with hypogastric abdominal pain and hematocolpos. No problems in adrenarche or thelarche were mentioned. The U/S and MRI revealed a normal cystic in the upper part of the vagina--hematocolpos varying from 42 × 26 × 30 to 73 × 55 × 32 mm. Three of the patients had an upper transverse vaginal septum while one had a middle transverse vaginal septum. Only one patient had a concomitant anomaly of the urinary system (ectopic kidney). In our patients, after laparoscopic examination 3 out of 4 patients had findings of endometriosis (2/3 with stage I-minimal endometriosis and 1/3 with stage II-mild endometriosis). CONCLUSION: Physicians should be aware of transverse vaginal septum in the differential diagnosis of hematocolpos with abdominal pain and primary amenorrhea in the early adolescent years. Early diagnosis could be based on premenarcheal gynecological examination and could lead to correct management in order to avoid the complications of endometriosis (dysmenorrhea or infertility).
Asunto(s)
Hematocolpos/cirugía , Vagina/anomalías , Enfermedades Vaginales/complicaciones , Dolor Abdominal/etiología , Adolescente , Amenorrea/etiología , Niño , Bases de Datos Factuales , Endometriosis/etiología , Femenino , Examen Ginecologíco , Hematocolpos/etiología , Humanos , Trastornos Mentales/etiología , Estudios Retrospectivos , Enfermedades Vaginales/congénito , Enfermedades Vaginales/diagnóstico , Enfermedades Vaginales/terapiaRESUMEN
Spontaneous preterm delivery, prematurity, and low birth weight due to prematurity account for a great part of neonatal morbidity and mortality. Specifically, chronic amniotic fluid inflammation may cause preterm labor, with the involvement of different mediators that produce diverse aspects of the inflammatory response. Although bacteria are considered to be the main trigger for intrauterine infection/inflammation, viral infections also appear to be involved. Recently, molecular genetic techniques have helped us better understand the underlying pathophysiologic processes. This is especially important because epidemiological and experimental studies indicate that intrauterine infection and inflammation constitute a risk factor for adverse neurological outcome in preterm infants. Chronic subclinical chorioamnionitis associated with preterm birth can also modify lung development. Although no current clinical strategy is aimed at adapting the maternofetal inflammatory response, immunomodulators may serve as a future intervention in preterm embryos.
Asunto(s)
Inflamación/complicaciones , Complicaciones Infecciosas del Embarazo , Nacimiento Prematuro/etiología , Enfermedades Uterinas/complicaciones , Corioamnionitis/epidemiología , Corioamnionitis/etiología , Corioamnionitis/mortalidad , Femenino , Humanos , Recién Nacido , Inflamación/epidemiología , Inflamación/mortalidad , Mortalidad Perinatal , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/mortalidad , Nacimiento Prematuro/epidemiología , Nacimiento Prematuro/mortalidad , Enfermedades Uterinas/epidemiología , Virosis/complicaciones , Virosis/epidemiología , Virosis/mortalidadRESUMEN
The aim of the study was to examine the frequency and relationship of peroxisome proliferator-activated receptor (PPAR)-γ and PPAR-δ gene polymorphisms to polycystic ovary syndrome (PCOS) characteristics. We conducted a case-control study protocol, which included 183 PCOS women and 148 healthy volunteers. Genetic, clinical, hormonal, and metabolic characteristics of PCOS patients and controls were estimated and compared. Genotype and allele frequencies did not differ significantly. The Pro(12) Ala polymorphism in exon 2 of the PPAR-γ gene was found in low frequency. Regarding the polymorphism in exon 6, the T-allele carrier PCOS women had significantly lower total testosterone levels. Regarding the +294T/C polymorphism in the exon 4 of the PPAR-δ gene, the C-allele carrier PCOS women had significantly higher fasting glucose levels. In conclusion, the PPAR-γ gene polymorphisms do not appear to affect the risk for PCOS, except for the reduced testosterone levels. The +294T/C polymorphism in the exon 4 of the PPAR-δ gene seems to cause an increase in fasting glucose levels.